nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—HTR2C—Sorafenib—thyroid cancer	0.225	0.329	CbGbCtD
Thioridazine—CYP2C8—Sorafenib—thyroid cancer	0.106	0.155	CbGbCtD
Thioridazine—CYP2C19—Sorafenib—thyroid cancer	0.0887	0.13	CbGbCtD
Thioridazine—CYP1A2—Sorafenib—thyroid cancer	0.0818	0.12	CbGbCtD
Thioridazine—CYP2C9—Sorafenib—thyroid cancer	0.0737	0.108	CbGbCtD
Thioridazine—CYP2D6—Sorafenib—thyroid cancer	0.0674	0.0987	CbGbCtD
Thioridazine—CYP2D6—Doxorubicin—thyroid cancer	0.0409	0.0599	CbGbCtD
Thioridazine—Sudden death—Vandetanib—thyroid cancer	0.0125	0.067	CcSEcCtD
Thioridazine—Torsade de pointes—Vandetanib—thyroid cancer	0.00909	0.0489	CcSEcCtD
Thioridazine—Ventricular arrhythmia—Vandetanib—thyroid cancer	0.00862	0.0463	CcSEcCtD
Thioridazine—Lethargy—Vandetanib—thyroid cancer	0.00472	0.0254	CcSEcCtD
Thioridazine—Cardiac arrest—Vandetanib—thyroid cancer	0.0044	0.0237	CcSEcCtD
Thioridazine—Gynaecomastia—Sorafenib—thyroid cancer	0.00385	0.0207	CcSEcCtD
Thioridazine—Photosensitivity reaction—Vandetanib—thyroid cancer	0.00365	0.0196	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.00331	0.0178	CcSEcCtD
Thioridazine—Arrhythmia—Vandetanib—thyroid cancer	0.00286	0.0154	CcSEcCtD
Thioridazine—Mental disorder—Vandetanib—thyroid cancer	0.00281	0.0151	CcSEcCtD
Thioridazine—Vision blurred—Vandetanib—thyroid cancer	0.00263	0.0141	CcSEcCtD
Thioridazine—Tremor—Vandetanib—thyroid cancer	0.00261	0.014	CcSEcCtD
Thioridazine—Eruption—Epirubicin—thyroid cancer	0.00258	0.0139	CcSEcCtD
Thioridazine—Eruption—Doxorubicin—thyroid cancer	0.00239	0.0129	CcSEcCtD
Thioridazine—Jaundice—Sorafenib—thyroid cancer	0.00235	0.0126	CcSEcCtD
Thioridazine—Oedema—Vandetanib—thyroid cancer	0.00228	0.0122	CcSEcCtD
Thioridazine—Thrombocytopenia—Vandetanib—thyroid cancer	0.00223	0.012	CcSEcCtD
Thioridazine—Ventricular arrhythmia—Epirubicin—thyroid cancer	0.00215	0.0115	CcSEcCtD
Thioridazine—Ventricular arrhythmia—Doxorubicin—thyroid cancer	0.00199	0.0107	CcSEcCtD
Thioridazine—Decreased appetite—Vandetanib—thyroid cancer	0.00198	0.0106	CcSEcCtD
Thioridazine—Constipation—Vandetanib—thyroid cancer	0.00195	0.0105	CcSEcCtD
Thioridazine—Arrhythmia—Sorafenib—thyroid cancer	0.00193	0.0104	CcSEcCtD
Thioridazine—Blood disorder—Epirubicin—thyroid cancer	0.0019	0.0102	CcSEcCtD
Thioridazine—Mental disorder—Sorafenib—thyroid cancer	0.00189	0.0102	CcSEcCtD
Thioridazine—Erythema—Sorafenib—thyroid cancer	0.00188	0.0101	CcSEcCtD
Thioridazine—Amenorrhoea—Epirubicin—thyroid cancer	0.00181	0.00973	CcSEcCtD
Thioridazine—Body temperature increased—Vandetanib—thyroid cancer	0.0018	0.00967	CcSEcCtD
Thioridazine—Blood disorder—Doxorubicin—thyroid cancer	0.00176	0.00947	CcSEcCtD
Thioridazine—Anaemia—Sorafenib—thyroid cancer	0.00174	0.00934	CcSEcCtD
Thioridazine—Angioedema—Sorafenib—thyroid cancer	0.00172	0.00924	CcSEcCtD
Thioridazine—Leukopenia—Sorafenib—thyroid cancer	0.00168	0.00905	CcSEcCtD
Thioridazine—Amenorrhoea—Doxorubicin—thyroid cancer	0.00167	0.009	CcSEcCtD
Thioridazine—Ventricular tachycardia—Epirubicin—thyroid cancer	0.00159	0.00855	CcSEcCtD
Thioridazine—Dermatitis contact—Epirubicin—thyroid cancer	0.00157	0.00845	CcSEcCtD
Thioridazine—Abnormal dreams—Epirubicin—thyroid cancer	0.00157	0.00845	CcSEcCtD
Thioridazine—Diarrhoea—Vandetanib—thyroid cancer	0.00156	0.00837	CcSEcCtD
Thioridazine—Thrombocytopenia—Sorafenib—thyroid cancer	0.0015	0.00808	CcSEcCtD
Thioridazine—Aplastic anaemia—Epirubicin—thyroid cancer	0.00149	0.00802	CcSEcCtD
Thioridazine—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.00147	0.00791	CcSEcCtD
Thioridazine—Anorexia—Sorafenib—thyroid cancer	0.00146	0.00787	CcSEcCtD
Thioridazine—Dermatitis contact—Doxorubicin—thyroid cancer	0.00145	0.00782	CcSEcCtD
Thioridazine—Abnormal dreams—Doxorubicin—thyroid cancer	0.00145	0.00782	CcSEcCtD
Thioridazine—Vomiting—Vandetanib—thyroid cancer	0.00145	0.00778	CcSEcCtD
Thioridazine—Rash—Vandetanib—thyroid cancer	0.00143	0.00771	CcSEcCtD
Thioridazine—Dermatitis—Vandetanib—thyroid cancer	0.00143	0.00771	CcSEcCtD
Thioridazine—Headache—Vandetanib—thyroid cancer	0.00143	0.00766	CcSEcCtD
Thioridazine—Aplastic anaemia—Doxorubicin—thyroid cancer	0.00138	0.00742	CcSEcCtD
Thioridazine—Nausea—Vandetanib—thyroid cancer	0.00135	0.00727	CcSEcCtD
Thioridazine—Decreased appetite—Sorafenib—thyroid cancer	0.00133	0.00717	CcSEcCtD
Thioridazine—Photosensitivity—Epirubicin—thyroid cancer	0.00131	0.00707	CcSEcCtD
Thioridazine—Constipation—Sorafenib—thyroid cancer	0.00131	0.00706	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00122	0.00658	CcSEcCtD
Thioridazine—Photosensitivity—Doxorubicin—thyroid cancer	0.00122	0.00654	CcSEcCtD
Thioridazine—Body temperature increased—Sorafenib—thyroid cancer	0.00121	0.00652	CcSEcCtD
Thioridazine—Lethargy—Epirubicin—thyroid cancer	0.00118	0.00633	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00113	0.00608	CcSEcCtD
Thioridazine—Hypersensitivity—Sorafenib—thyroid cancer	0.00113	0.00608	CcSEcCtD
Thioridazine—Cardiac arrest—Epirubicin—thyroid cancer	0.0011	0.0059	CcSEcCtD
Thioridazine—Lethargy—Doxorubicin—thyroid cancer	0.00109	0.00586	CcSEcCtD
Thioridazine—Diarrhoea—Sorafenib—thyroid cancer	0.00105	0.00565	CcSEcCtD
Thioridazine—Cardiac arrest—Doxorubicin—thyroid cancer	0.00102	0.00546	CcSEcCtD
Thioridazine—Asthma—Epirubicin—thyroid cancer	0.000998	0.00536	CcSEcCtD
Thioridazine—Eosinophilia—Epirubicin—thyroid cancer	0.000988	0.00531	CcSEcCtD
Thioridazine—Vomiting—Sorafenib—thyroid cancer	0.000976	0.00525	CcSEcCtD
Thioridazine—Rash—Sorafenib—thyroid cancer	0.000968	0.0052	CcSEcCtD
Thioridazine—Dermatitis—Sorafenib—thyroid cancer	0.000967	0.0052	CcSEcCtD
Thioridazine—Headache—Sorafenib—thyroid cancer	0.000962	0.00517	CcSEcCtD
Thioridazine—Pancytopenia—Epirubicin—thyroid cancer	0.000947	0.00509	CcSEcCtD
Thioridazine—Asthma—Doxorubicin—thyroid cancer	0.000923	0.00496	CcSEcCtD
Thioridazine—Eosinophilia—Doxorubicin—thyroid cancer	0.000914	0.00491	CcSEcCtD
Thioridazine—Nausea—Sorafenib—thyroid cancer	0.000912	0.0049	CcSEcCtD
Thioridazine—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000911	0.00489	CcSEcCtD
Thioridazine—Weight increased—Epirubicin—thyroid cancer	0.000908	0.00488	CcSEcCtD
Thioridazine—Drowsiness—Epirubicin—thyroid cancer	0.000889	0.00478	CcSEcCtD
Thioridazine—Pancytopenia—Doxorubicin—thyroid cancer	0.000877	0.00471	CcSEcCtD
Thioridazine—Jaundice—Epirubicin—thyroid cancer	0.000867	0.00466	CcSEcCtD
Thioridazine—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000842	0.00453	CcSEcCtD
Thioridazine—Weight increased—Doxorubicin—thyroid cancer	0.00084	0.00452	CcSEcCtD
Thioridazine—Agranulocytosis—Epirubicin—thyroid cancer	0.00083	0.00446	CcSEcCtD
Thioridazine—Drowsiness—Doxorubicin—thyroid cancer	0.000823	0.00442	CcSEcCtD
Thioridazine—Jaundice—Doxorubicin—thyroid cancer	0.000802	0.00431	CcSEcCtD
Thioridazine—Oedema peripheral—Epirubicin—thyroid cancer	0.000787	0.00423	CcSEcCtD
Thioridazine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000768	0.00413	CcSEcCtD
Thioridazine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000728	0.00391	CcSEcCtD
Thioridazine—Arrhythmia—Epirubicin—thyroid cancer	0.000713	0.00383	CcSEcCtD
Thioridazine—Mental disorder—Epirubicin—thyroid cancer	0.0007	0.00376	CcSEcCtD
Thioridazine—Erythema—Epirubicin—thyroid cancer	0.000695	0.00374	CcSEcCtD
Thioridazine—Arrhythmia—Doxorubicin—thyroid cancer	0.00066	0.00355	CcSEcCtD
Thioridazine—Vision blurred—Epirubicin—thyroid cancer	0.000655	0.00352	CcSEcCtD
Thioridazine—Mental disorder—Doxorubicin—thyroid cancer	0.000647	0.00348	CcSEcCtD
Thioridazine—Erythema—Doxorubicin—thyroid cancer	0.000643	0.00346	CcSEcCtD
Thioridazine—Anaemia—Epirubicin—thyroid cancer	0.000642	0.00345	CcSEcCtD
Thioridazine—Agitation—Epirubicin—thyroid cancer	0.000639	0.00343	CcSEcCtD
Thioridazine—Leukopenia—Epirubicin—thyroid cancer	0.000622	0.00334	CcSEcCtD
Thioridazine—Vision blurred—Doxorubicin—thyroid cancer	0.000606	0.00326	CcSEcCtD
Thioridazine—Anaemia—Doxorubicin—thyroid cancer	0.000594	0.0032	CcSEcCtD
Thioridazine—Agitation—Doxorubicin—thyroid cancer	0.000591	0.00318	CcSEcCtD
Thioridazine—Leukopenia—Doxorubicin—thyroid cancer	0.000576	0.00309	CcSEcCtD
Thioridazine—Confusional state—Epirubicin—thyroid cancer	0.000572	0.00307	CcSEcCtD
Thioridazine—Oedema—Epirubicin—thyroid cancer	0.000567	0.00305	CcSEcCtD
Thioridazine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000555	0.00299	CcSEcCtD
Thioridazine—Tachycardia—Epirubicin—thyroid cancer	0.000554	0.00298	CcSEcCtD
Thioridazine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000548	0.00295	CcSEcCtD
Thioridazine—Anorexia—Epirubicin—thyroid cancer	0.000541	0.00291	CcSEcCtD
Thioridazine—Hypotension—Epirubicin—thyroid cancer	0.00053	0.00285	CcSEcCtD
Thioridazine—Confusional state—Doxorubicin—thyroid cancer	0.000529	0.00284	CcSEcCtD
Thioridazine—Oedema—Doxorubicin—thyroid cancer	0.000525	0.00282	CcSEcCtD
Thioridazine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000514	0.00276	CcSEcCtD
Thioridazine—Tachycardia—Doxorubicin—thyroid cancer	0.000512	0.00275	CcSEcCtD
Thioridazine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000507	0.00273	CcSEcCtD
Thioridazine—Somnolence—Epirubicin—thyroid cancer	0.000504	0.00271	CcSEcCtD
Thioridazine—Anorexia—Doxorubicin—thyroid cancer	0.0005	0.00269	CcSEcCtD
Thioridazine—Decreased appetite—Epirubicin—thyroid cancer	0.000493	0.00265	CcSEcCtD
Thioridazine—Hypotension—Doxorubicin—thyroid cancer	0.00049	0.00264	CcSEcCtD
Thioridazine—Constipation—Epirubicin—thyroid cancer	0.000485	0.00261	CcSEcCtD
Thioridazine—Feeling abnormal—Epirubicin—thyroid cancer	0.000467	0.00251	CcSEcCtD
Thioridazine—Somnolence—Doxorubicin—thyroid cancer	0.000467	0.00251	CcSEcCtD
Thioridazine—Decreased appetite—Doxorubicin—thyroid cancer	0.000456	0.00245	CcSEcCtD
Thioridazine—Constipation—Doxorubicin—thyroid cancer	0.000449	0.00241	CcSEcCtD
Thioridazine—Body temperature increased—Epirubicin—thyroid cancer	0.000448	0.00241	CcSEcCtD
Thioridazine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000433	0.00233	CcSEcCtD
Thioridazine—Hypersensitivity—Epirubicin—thyroid cancer	0.000418	0.00225	CcSEcCtD
Thioridazine—Body temperature increased—Doxorubicin—thyroid cancer	0.000415	0.00223	CcSEcCtD
Thioridazine—Diarrhoea—Epirubicin—thyroid cancer	0.000388	0.00209	CcSEcCtD
Thioridazine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000387	0.00208	CcSEcCtD
Thioridazine—Vomiting—Epirubicin—thyroid cancer	0.000361	0.00194	CcSEcCtD
Thioridazine—Diarrhoea—Doxorubicin—thyroid cancer	0.000359	0.00193	CcSEcCtD
Thioridazine—Rash—Epirubicin—thyroid cancer	0.000358	0.00192	CcSEcCtD
Thioridazine—Dermatitis—Epirubicin—thyroid cancer	0.000357	0.00192	CcSEcCtD
Thioridazine—Headache—Epirubicin—thyroid cancer	0.000355	0.00191	CcSEcCtD
Thioridazine—Nausea—Epirubicin—thyroid cancer	0.000337	0.00181	CcSEcCtD
Thioridazine—Vomiting—Doxorubicin—thyroid cancer	0.000334	0.00179	CcSEcCtD
Thioridazine—Rash—Doxorubicin—thyroid cancer	0.000331	0.00178	CcSEcCtD
Thioridazine—Dermatitis—Doxorubicin—thyroid cancer	0.000331	0.00178	CcSEcCtD
Thioridazine—Headache—Doxorubicin—thyroid cancer	0.000329	0.00177	CcSEcCtD
Thioridazine—Nausea—Doxorubicin—thyroid cancer	0.000312	0.00168	CcSEcCtD
Thioridazine—DRD2—Signaling Pathways—CDK1—thyroid cancer	4.49e-05	0.000343	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.49e-05	0.000343	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—RXRA—thyroid cancer	4.47e-05	0.000341	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CALCA—thyroid cancer	4.44e-05	0.000339	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CDK1—thyroid cancer	4.42e-05	0.000338	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CDK1—thyroid cancer	4.41e-05	0.000337	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CDK1—thyroid cancer	4.34e-05	0.000332	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CDK1—thyroid cancer	4.33e-05	0.000331	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TERT—thyroid cancer	4.29e-05	0.000328	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—NRAS—thyroid cancer	4.26e-05	0.000325	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—SLC5A5—thyroid cancer	4.22e-05	0.000322	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—NRAS—thyroid cancer	4.2e-05	0.000321	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—NRAS—thyroid cancer	4.19e-05	0.00032	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—NRG1—thyroid cancer	4.11e-05	0.000314	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—HIF1A—thyroid cancer	4.1e-05	0.000313	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—RXRA—thyroid cancer	4.1e-05	0.000313	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.09e-05	0.000312	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—NRG1—thyroid cancer	4.09e-05	0.000312	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CDK1—thyroid cancer	4.02e-05	0.000307	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.95e-05	0.000302	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—BRAF—thyroid cancer	3.95e-05	0.000301	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—BRAF—thyroid cancer	3.94e-05	0.000301	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—TPR—thyroid cancer	3.92e-05	0.000299	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—NRG1—thyroid cancer	3.91e-05	0.000299	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	3.86e-05	0.000295	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—SLC5A5—thyroid cancer	3.77e-05	0.000288	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TERT—thyroid cancer	3.69e-05	0.000282	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TERT—thyroid cancer	3.67e-05	0.00028	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—KRAS—thyroid cancer	3.66e-05	0.00028	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—NRAS—thyroid cancer	3.61e-05	0.000276	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—KRAS—thyroid cancer	3.61e-05	0.000276	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—KRAS—thyroid cancer	3.61e-05	0.000276	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NRG1—thyroid cancer	3.61e-05	0.000276	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NRG1—thyroid cancer	3.55e-05	0.000271	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—RXRA—thyroid cancer	3.54e-05	0.000271	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NRG1—thyroid cancer	3.54e-05	0.000271	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.53e-05	0.000269	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—HIF1A—thyroid cancer	3.53e-05	0.000269	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TERT—thyroid cancer	3.51e-05	0.000268	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—HIF1A—thyroid cancer	3.51e-05	0.000268	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.5e-05	0.000267	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NRG1—thyroid cancer	3.49e-05	0.000266	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NRG1—thyroid cancer	3.48e-05	0.000265	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	3.46e-05	0.000265	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.45e-05	0.000263	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—SLC5A5—thyroid cancer	3.43e-05	0.000262	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—BRAF—thyroid cancer	3.4e-05	0.000259	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—HIF1A—thyroid cancer	3.36e-05	0.000257	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—TP53—thyroid cancer	3.26e-05	0.000249	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TERT—thyroid cancer	3.24e-05	0.000247	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	3.23e-05	0.000247	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.22e-05	0.000246	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TERT—thyroid cancer	3.19e-05	0.000243	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TERT—thyroid cancer	3.18e-05	0.000243	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—RXRA—thyroid cancer	3.16e-05	0.000242	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TERT—thyroid cancer	3.13e-05	0.000239	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TERT—thyroid cancer	3.12e-05	0.000238	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—HRAS—thyroid cancer	3.11e-05	0.000238	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—KRAS—thyroid cancer	3.11e-05	0.000238	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—NRAS—thyroid cancer	3.11e-05	0.000237	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—HIF1A—thyroid cancer	3.1e-05	0.000237	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—NRAS—thyroid cancer	3.09e-05	0.000236	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.08e-05	0.000235	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—HRAS—thyroid cancer	3.07e-05	0.000235	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—HRAS—thyroid cancer	3.07e-05	0.000234	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—HIF1A—thyroid cancer	3.05e-05	0.000233	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—HIF1A—thyroid cancer	3.04e-05	0.000232	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—HIF1A—thyroid cancer	2.99e-05	0.000229	CbGpPWpGaD
Thioridazine—HTR6—GPCR downstream signaling—AKT1—thyroid cancer	2.99e-05	0.000228	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—HIF1A—thyroid cancer	2.98e-05	0.000228	CbGpPWpGaD
Thioridazine—HTR7—GPCR downstream signaling—AKT1—thyroid cancer	2.98e-05	0.000228	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—NRAS—thyroid cancer	2.96e-05	0.000226	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	2.93e-05	0.000224	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—BRAF—thyroid cancer	2.92e-05	0.000223	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—RXRA—thyroid cancer	2.91e-05	0.000222	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—BRAF—thyroid cancer	2.91e-05	0.000222	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TERT—thyroid cancer	2.9e-05	0.000221	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—RXRA—thyroid cancer	2.88e-05	0.00022	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—CCND1—thyroid cancer	2.88e-05	0.00022	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—CCND1—thyroid cancer	2.88e-05	0.00022	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PPARG—thyroid cancer	2.82e-05	0.000215	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.81e-05	0.000214	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—BRAF—thyroid cancer	2.78e-05	0.000212	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—PTEN—thyroid cancer	2.78e-05	0.000212	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—PTEN—thyroid cancer	2.78e-05	0.000212	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	2.77e-05	0.000212	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—AKT1—thyroid cancer	2.75e-05	0.00021	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.75e-05	0.00021	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—NRAS—thyroid cancer	2.73e-05	0.000208	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—AKT1—thyroid cancer	2.71e-05	0.000207	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—AKT1—thyroid cancer	2.71e-05	0.000207	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—NRAS—thyroid cancer	2.69e-05	0.000205	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—NRAS—thyroid cancer	2.68e-05	0.000205	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	2.68e-05	0.000204	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	2.66e-05	0.000203	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—HRAS—thyroid cancer	2.64e-05	0.000202	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—NRAS—thyroid cancer	2.64e-05	0.000201	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—NRAS—thyroid cancer	2.63e-05	0.000201	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PPARG—thyroid cancer	2.59e-05	0.000198	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—AKT1—thyroid cancer	2.57e-05	0.000196	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—BRAF—thyroid cancer	2.57e-05	0.000196	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—KRAS—thyroid cancer	2.55e-05	0.000195	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—BRAF—thyroid cancer	2.52e-05	0.000193	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—BRAF—thyroid cancer	2.52e-05	0.000192	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—NRAS—thyroid cancer	2.48e-05	0.000189	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CCND1—thyroid cancer	2.48e-05	0.000189	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—BRAF—thyroid cancer	2.48e-05	0.000189	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—NRAS—thyroid cancer	2.48e-05	0.000189	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	2.47e-05	0.000189	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—RXRA—thyroid cancer	2.47e-05	0.000188	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	2.44e-05	0.000187	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.4e-05	0.000183	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—PTEN—thyroid cancer	2.39e-05	0.000183	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—KRAS—thyroid cancer	2.35e-05	0.000179	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—AKT1—thyroid cancer	2.33e-05	0.000178	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	2.31e-05	0.000177	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—KRAS—thyroid cancer	2.31e-05	0.000176	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	2.3e-05	0.000175	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	2.27e-05	0.000174	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—KRAS—thyroid cancer	2.27e-05	0.000173	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	2.26e-05	0.000173	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	2.26e-05	0.000173	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PPARG—thyroid cancer	2.24e-05	0.000171	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PTGS2—thyroid cancer	2.22e-05	0.000169	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	2.21e-05	0.000169	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	2.2e-05	0.000168	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—HRAS—thyroid cancer	2.17e-05	0.000165	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—NRAS—thyroid cancer	2.14e-05	0.000163	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—KRAS—thyroid cancer	2.13e-05	0.000163	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—KRAS—thyroid cancer	2.13e-05	0.000163	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CCND1—thyroid cancer	2.13e-05	0.000163	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CCND1—thyroid cancer	2.12e-05	0.000162	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—AKT1—thyroid cancer	2.11e-05	0.000161	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	2.1e-05	0.000161	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PTEN—thyroid cancer	2.06e-05	0.000157	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PTEN—thyroid cancer	2.05e-05	0.000156	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTGS2—thyroid cancer	2.04e-05	0.000156	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CCND1—thyroid cancer	2.03e-05	0.000155	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	2.01e-05	0.000153	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PPARG—thyroid cancer	2e-05	0.000153	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	2e-05	0.000153	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—HRAS—thyroid cancer	2e-05	0.000152	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	1.96e-05	0.00015	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—HRAS—thyroid cancer	1.96e-05	0.00015	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PTEN—thyroid cancer	1.96e-05	0.00015	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	1.94e-05	0.000148	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PTEN—thyroid cancer	1.93e-05	0.000148	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—HRAS—thyroid cancer	1.93e-05	0.000147	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	1.92e-05	0.000147	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—AKT1—thyroid cancer	1.91e-05	0.000146	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	1.91e-05	0.000146	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—AKT1—thyroid cancer	1.91e-05	0.000146	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TP53—thyroid cancer	1.9e-05	0.000145	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TP53—thyroid cancer	1.9e-05	0.000145	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—AKT1—thyroid cancer	1.88e-05	0.000143	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCND1—thyroid cancer	1.87e-05	0.000143	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	1.87e-05	0.000143	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCND1—thyroid cancer	1.84e-05	0.000141	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCND1—thyroid cancer	1.84e-05	0.00014	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—KRAS—thyroid cancer	1.84e-05	0.00014	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PPARG—thyroid cancer	1.84e-05	0.00014	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—NRAS—thyroid cancer	1.84e-05	0.00014	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—NRAS—thyroid cancer	1.83e-05	0.00014	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PPARG—thyroid cancer	1.82e-05	0.000139	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—HRAS—thyroid cancer	1.81e-05	0.000139	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—HRAS—thyroid cancer	1.81e-05	0.000138	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCND1—thyroid cancer	1.81e-05	0.000138	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PTEN—thyroid cancer	1.81e-05	0.000138	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	1.8e-05	0.000138	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	1.79e-05	0.000136	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PTEN—thyroid cancer	1.78e-05	0.000136	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTEN—thyroid cancer	1.78e-05	0.000136	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PTEN—thyroid cancer	1.77e-05	0.000135	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—AKT1—thyroid cancer	1.76e-05	0.000135	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTGS2—thyroid cancer	1.76e-05	0.000134	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—NRAS—thyroid cancer	1.75e-05	0.000134	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PTEN—thyroid cancer	1.75e-05	0.000133	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	1.74e-05	0.000133	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	1.74e-05	0.000133	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	1.73e-05	0.000132	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—AKT1—thyroid cancer	1.73e-05	0.000132	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—AKT1—thyroid cancer	1.7e-05	0.00013	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	1.7e-05	0.00013	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	1.68e-05	0.000128	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TP53—thyroid cancer	1.63e-05	0.000125	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	1.62e-05	0.000124	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NRAS—thyroid cancer	1.61e-05	0.000123	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—AKT1—thyroid cancer	1.6e-05	0.000122	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—AKT1—thyroid cancer	1.6e-05	0.000122	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NRAS—thyroid cancer	1.59e-05	0.000121	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NRAS—thyroid cancer	1.58e-05	0.000121	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—KRAS—thyroid cancer	1.58e-05	0.000121	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	1.58e-05	0.000121	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—KRAS—thyroid cancer	1.57e-05	0.00012	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTGS2—thyroid cancer	1.57e-05	0.00012	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—HRAS—thyroid cancer	1.56e-05	0.000119	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NRAS—thyroid cancer	1.56e-05	0.000119	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PPARG—thyroid cancer	1.56e-05	0.000119	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	1.55e-05	0.000119	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTEN—thyroid cancer	1.54e-05	0.000117	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—KRAS—thyroid cancer	1.5e-05	0.000115	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTGS2—thyroid cancer	1.45e-05	0.00011	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	1.44e-05	0.00011	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTGS2—thyroid cancer	1.43e-05	0.000109	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TP53—thyroid cancer	1.4e-05	0.000107	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TP53—thyroid cancer	1.4e-05	0.000107	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—KRAS—thyroid cancer	1.39e-05	0.000106	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AKT1—thyroid cancer	1.38e-05	0.000105	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTEN—thyroid cancer	1.37e-05	0.000105	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—KRAS—thyroid cancer	1.37e-05	0.000104	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—KRAS—thyroid cancer	1.36e-05	0.000104	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—HRAS—thyroid cancer	1.34e-05	0.000103	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—KRAS—thyroid cancer	1.34e-05	0.000102	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TP53—thyroid cancer	1.34e-05	0.000102	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	1.34e-05	0.000102	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—HRAS—thyroid cancer	1.34e-05	0.000102	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—HRAS—thyroid cancer	1.28e-05	9.77e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTEN—thyroid cancer	1.26e-05	9.63e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTEN—thyroid cancer	1.25e-05	9.54e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	1.24e-05	9.49e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TP53—thyroid cancer	1.23e-05	9.42e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTGS2—thyroid cancer	1.22e-05	9.35e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TP53—thyroid cancer	1.21e-05	9.27e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TP53—thyroid cancer	1.21e-05	9.25e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TP53—thyroid cancer	1.19e-05	9.1e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TP53—thyroid cancer	1.19e-05	9.07e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AKT1—thyroid cancer	1.19e-05	9.06e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AKT1—thyroid cancer	1.18e-05	9.01e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—HRAS—thyroid cancer	1.18e-05	9.01e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—HRAS—thyroid cancer	1.16e-05	8.86e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—HRAS—thyroid cancer	1.16e-05	8.84e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—HRAS—thyroid cancer	1.14e-05	8.7e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	1.14e-05	8.68e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AKT1—thyroid cancer	1.13e-05	8.63e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—AKT1—thyroid cancer	1.11e-05	8.51e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TP53—thyroid cancer	1.1e-05	8.43e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTEN—thyroid cancer	1.07e-05	8.16e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	1.06e-05	8.06e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AKT1—thyroid cancer	1.04e-05	7.95e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AKT1—thyroid cancer	1.02e-05	7.83e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—AKT1—thyroid cancer	1.02e-05	7.82e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AKT1—thyroid cancer	1.02e-05	7.81e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AKT1—thyroid cancer	1.01e-05	7.68e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	1e-05	7.66e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	9.32e-06	7.12e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—AKT1—thyroid cancer	8.85e-06	6.76e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—AKT1—thyroid cancer	7.9e-06	6.03e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—AKT1—thyroid cancer	7.26e-06	5.55e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—AKT1—thyroid cancer	7.2e-06	5.5e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—AKT1—thyroid cancer	6.15e-06	4.7e-05	CbGpPWpGaD
